Comments
Sun Pharma Advanced Research Company (SPARC) today said its net loss widened to Rs 24.09 crore for the third quarter ended December 31, 2012.
The company had posted a net loss of Rs 17.90 crore during the same period of the previous fiscal, Sun Pharma Advanced Research Company said in a BSE filing.
Total income declined to Rs 4.22 crore during the quarter as against Rs 4.51 crore during the same period of 2011-12.
The company was demerged from Sun Pharma as a pharma research and drug discovery company in 2007.
Shares of SPARC today closed at Rs 112.15 on the BSE, down 6.70 per cent from their previous close.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.